Pharmacology News

Many factors have contributed to the recent surge in adult ADHD diagnoses, but the rise is mostly reflective of what has always existed and gone undetected, according to experts.

Researchers found that a questionnaire successfully identified patients with STIs who can be safely evaluated for penicillin allergy by skin test or by a two-step graded oral challenge, according to a study.

As healers, we are most comfortable and confident when we can rely on the long-established armamentarium of countless medications created by the American pharmaceutical industry.

The average number of inappropriate antibiotics prescribed monthly decreased at the start of the COVID-19 pandemic but returned to pre-pandemic levels by late 2021, data show.

Individuals prescribed the antidiabetes treatment metformin less likely developed a myeloproliferative neoplasm —potentially also reducing a person’s chances for developing certain cancers — according to data published in Blood Advances.

The addition of azithromycin to daily trimethoprim-sulfamethoxazole treatment among pregnant women with HIV did not reduce the rate of malaria or bacterial sexually transmitted infections at delivery, data show.

Patients have become increasingly disillusioned with traditional depression treatments, and the search for new therapies has created some chaos in the field, according to experts.

BOSTON —Small interfering RNA technology has the potential to become a novel treatment approach in cardiovascular medicine, according to Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA.

BOSTON — Emerging data on the cardiovascular benefits of GLP-1 receptor agonists indicate that these agents could transform cardiovascular care, much like statins did 30 years ago, Clyde W. Yancy, MD, MSc, MACP, MACC, FAHA, FHFSA, said.

BOSTON — A “laundry list of new trials” in cardiovascular medicine has led to “a decided portfolio of new ways of thinking, new interventions and a new potential to modify the natural history of CVD,” an expert said.